Article info
PDFReview
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- Correspondence to Professor P Mitchell, Eye Clinic (B4A), Westmead Hospital, Hawkesbury Road, Westmead, NSW, 2145, Australia; paul_mitchell{at}wmi.usyd.edu.au
Citation
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
Publication history
- Accepted April 29, 2009
- First published May 13, 2009.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- Previous version (22 March 2016).
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd. All rights reserved.